Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors
| Autor: | Zhou, Yue, Wang, Bo, Qu, Jinghan, Yu, Fan, Zhao, Yang, Li, Shuyan, Zeng, Ya, Yang, Xi, Chu, Li, Chu, Xiao, Li, Yida, Zou, Liqing, Guo, Tiantian, Ye, Luxi, Liang, Fei, Wang, Shengping, Liu, Quan, Ni, Jianjiao *, Zhu, Zhengfei * |
|---|---|
| Zdroj: | In Lung Cancer December 2020 150:178-185 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect